Summary
Between February 1984 and November 1989, 188 orthotopic cardiac transplants were performed at St Vincent’s Hospital, Sydney, in 183 patients. Five patients required retransplantation. All patients were in New York Heart Association Functional Class III to IV before transplantation. Thirty-four of these patients were female and 149 male. Recipient diagnosis in 98 patients was primary cardiomyopathy, while 71 had ischemic heart disease, 13 had valvular heart disease, and 1 patient had congenital heart disease. Three different immunosuppressive protocols have been used: cyclosporin A (CsA) + prednisolone (P), CsA + azathioprine (Aza) + P, and CsA + Aza. Antithymocyte globulin (ATG) was administered for a 7-day period in all groups. Subsequently, there was a prospective trial comparing OKT3 to ATG for prophylactic immunosuppression - there was one death in the OKT3 group due to rejection. There have been 28 deaths overall. From our experience, a combination of CsA and Aza, with or without the addition of prednisolone, has improved our actuarial 5-year survival, which has risen from 68% (CsA + P), to 82.7% (CsA + Aza + P) or 90.48% (CsA + Aza). Our experience demonstrates that with orthotopic heart tranplantation, 1-year survival in excess of 90% and a 5-year survival of 85% can be achieved in patients ranging in age from 9 years to 65 years. The majority of patients return to a productive lifestyle, with 75% returning to employment, home duties, or study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chang VP (1984) Reintroduction of cardiac transplantation in Australia. Med J Aust 140:692–693
Oyer PE, Stinson EB, Jamieson SW, et al. (1983) Cyclosporin in cardiac transplantation: 21/2 years’ follow-up. Transplant Proc 15:2546–2552
Chang VP, Spratt PM, Baron D (1985) Selection of patients for cardiac transplantation. Med J Aust 142: 288–289
Windsor H (1969) Heart transplantation: Surgical and post-operative surgical aspects. Med J Aust 1:666–670
Jones BM, Chang VP, Baron D (1985). The social and emotional impact of cardiac transplantation. Proceedings of International Symposium on Cardiovascular Surgery
Esmore DS, Spratt PM, Chang VP, et al. (1988) Cyclosporin-A and azathioprine without maintenance steroids: A prospective randomised trial. Proc Int Heart Transplant Soc
Jones BM, Taylor F, McBride M, et al. (to be published) Rehabilitation and quality of life after cardiac transplantation.
Gallagher D, Keogh A, Baron D, Chang VP, et al. (1989) Accelerated coronary artery disease following cardiac transplantation. Aust NZ J Med 19(5):563
Spratt PM, Sivathasan C, MacDonald P, et al. (to be published) Role of routine endomyocardial biopsy for monitoring late rejection after cardiac transplantation.
Keogh A, Harvison A, Chang VP, et al. (1988) Exercise tolerance following cardiac transplantation (abstract). Aust NZ J Med 18 (3, Suppl 2):353
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Tokyo
About this paper
Cite this paper
Chang, V.P., Raman, J., Keogh, A., McDonald, P., Farnsworth, A.E., Spratt, P.M. (1991). Cardiac transplantation: Australian results. In: Akutsu, T., et al. Artificial Heart 3. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68126-7_30
Download citation
DOI: https://doi.org/10.1007/978-4-431-68126-7_30
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68128-1
Online ISBN: 978-4-431-68126-7
eBook Packages: Springer Book Archive